Zhiqiang Zhu
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance.
Journal: PloS one
Published: October 16, 2025
Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer.
Journal: International journal of general medicine
Published: February 07, 2025
TRIP13-induced NUSAP1 upregulation promotes CcRCC progression through EMT and PI3K/AKT/mTOR pathway.
TRIP13-induced NUSAP1 upregulation promotes CcRCC progression through EMT and PI3K/AKT/mTOR pathway.
Journal: Journal of translational medicine
Published: January 23, 2025
BRD7 facilitates ferroptosis via modulating clusterin promoter hypermethylation and suppressing AMPK signaling in diabetes-induced testicular damage.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 13, 2024
Rbbp6-Mediated Bmal1 Ubiquitination Inhibits YAP1 Signaling Pathway to Promote Ferroptosis in Diabetes-Induced Testicular Damage.
Journal: Diabetes & metabolism journal
Published: March 01, 2024
LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: March 04, 2020
Diagnostic Value of Urine Cytology in Bladder Cancer. A Meta-Analysis.
Journal: Analytical and quantitative cytopathology and histopathology
Published: July 02, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026